The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention

https://doi.org/10.1053/j.ajkd.2008.06.037Get rights and content

Kidney disease is the ninth leading cause of death in the United States. In 2000, more than 26 million adults were estimated to have chronic kidney disease (CKD), placing them at risk of progressing to kidney failure. The number of new cases of kidney failure treated by using dialysis or transplantation in the United States has more than doubled since 1990, and it is expected to continue to increase with the aging of the population and the increasing prevalence of such risk factors as diabetes. In recognition of this problem, Congress passed legislation to build capacity and infrastructure at the Centers for Disease Control and Prevention (CDC) for a public health approach to CKD. This Kidney Disease Initiative at the CDC includes surveillance, epidemiology, state-based demonstration projects, and economic studies. The objectives, in collaboration with partners, are to assess and monitor the burden of CKD in the United States, determine its risk factors and rates of preventive practices, develop methods to identify and monitor populations at risk of developing CKD, document the costs of kidney disease, and develop models to help predict the progression of this disease and test the cost-effectiveness of various public health strategies for preventing CKD.

Section snippets

Surveillance and Epidemiology

The CDC is collaborating with partners from the University of Michigan and Johns Hopkins University to develop and establish a surveillance system for all stages of CKD that could monitor national trends and identify research needs. This activity entails identifying the relevant data sources and measures for a CKD surveillance system that would work seamlessly with other kidney-related surveillance efforts, such as the US Renal Data System (USRDS) and the National Diabetes Surveillance System

The DDT at the CDC

Through the DDT, the CDC seeks to eliminate the preventable burden of diabetes through leadership, research, programs, and policies that translate science into practice. The CDC works with partners to provide a national surveillance system for diabetes, provide support and recommendations for public health decisions, promote management practices to ensure good care and education for people with diabetes, and inform the public about the disease.

A key component of the DDT surveillance activities

Conclusion

The CDC will continue to work with its partners to strengthen the surveillance of diabetes and its complications (including kidney disease) and support prevention research, public health interventions, and education. In the case of CKD, increased awareness, early detection and evaluation, and improved treatment for patients with the earlier disease stages and its risk factors are critical to delay or prevent the development, progression, and complications of this disease in the population at

Acknowledgements

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.

Support: None.

Financial Disclosure: None.

References (33)

  • J. Coresh et al.

    Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

    Am J Kidney Dis

    (2003)
  • M.P. Heron et al.

    Deaths: Preliminary Data for 2006

    Natl Vital Stat Rep

    (2008)
  • J. Coresh et al.

    Prevalence of chronic kidney disease in the United States

    JAMA

    (2007)
  • USRDS 2007 Annual Data Report

    (2007)
  • B.M. Brenner et al.

    Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

    N Engl J Med

    (2001)
  • National Diabetes Surveillance System

  • Kidney Disease Initiative

  • Health ABC Description

  • Kidney Early Evaluation Program (KEEP) annual data report 2006

    Am J Kidney Dis

    (2007)
  • Healthy People 2010With Understanding and Improving Health and Objectives for Improving Health

    (2000)
  • Nephropathy in diabetes

    Diabetes Care

    (2004)
  • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

    N Engl J Med

    (1993)
  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

    Lancet

    (1998)
  • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)

    BMJ

    (1998)
  • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)

    BMJ

    (1998)
  • E.J. Lewis et al.

    Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

    N Engl J Med

    (2001)
  • Cited by (9)

    • Hydration and Health

      2019, Analysis in Nutrition Research: Principles of Statistical Methodology and Interpretation of the Results
    • Hydration and health

      2018, Analysis in Nutrition Research: Principles of Statistical Methodology and Interpretation of the Results
    View all citing articles on Scopus
    View full text